Recall: D-0673-2026

Class II - Potentially Harmful

Class IIClassification

2026-06-24Initiated

OngoingStatus

Reliance Life Sciences PrivateFirm

Product

Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01

Reason

Lack of Sterility Assurance

Distribution

Nationwide in the USA

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.